Clinical trials for breast cancer

99 currently recruiting clinical trials

Phase 2 Breast cancer #NCT05296746
HER2 Negative HR Positive Localized None Systemic Treatment-Naive Systemic Treatment-Naive
Clinique Sainte Anne (Strasbourg), Clinique Pasteur (Toulouse), Centre Eugene Marquis (Rennes), Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne) (and 26 more...)
Novartis
Phase 2 Breast cancer #NCT06465368
HER2 Negative HR Positive Localized None Systemic Treatment-Naive
Surgery Radiotherapy
Gustave Roussy (Villejuif), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Pfizer
Phase 2 Breast cancer #NCT02264678
HER2 Negative HER2 Low HER2 Positive Locally Advanced Metastatic BRCA 1/2 1 2
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Léon Bérard (Lyon)
AstraZeneca
Phase 2 Breast cancer #NCT06172127
HER2 Positive Locally Advanced Metastatic None Systemic Treatment-Naive
Chemotherapy Targeted therapy
Hôpital Tenon AP-HP (Paris ), Institut Paoli-Calmettes (Marseille), Hôpital Européen Georges Pompidou - AP-HP (Paris)
Phase 2 Breast cancer #NCT04423029
HER2 Negative HR Negative Locally Advanced Metastatic
Systemic Treatment-Naive
Centre Hospitalier​ Universitaire de Bordeaux (Bordeaux), Hôpital Saint Louis AP-HP (Paris)
Bristol-Myers Squibb
Phase 2 Breast cancer #NCT06450314
HER2 Positive Locally Advanced Metastatic 1 2 3 or more Targeted therapy
Systemic Treatment-Naive
Centre François Baclesse (Caen ), Centre Hospitalier Simone Veil de Beauvais (Beauvais), Gustave Roussy (Villejuif)
UNICANCER
Phase 2 Breast cancer #NCT06508216
HER2 Negative HR Negative Locally Advanced Metastatic None Chemotherapy Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 2 Breast cancer #NCT06162351
HER2 Negative HER2 Low HR Negative Locally Advanced Metastatic 2 3 or more Chemotherapy Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Institut Curie - Paris (Paris), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud)
Institut Curie
Phase 2 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer #NCT03767075
Locally Advanced Metastatic Metastatic Castration-resistant BRCA 1/2 CDK12 EGFR FGFR MET MSI/dMMR Other mutation
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Institut d'oncologie du Vall d'Hebron
Phase 2 Breast cancer #NCT04680715
HER2 Negative HR Positive Localized None Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice)
Centre Antoine Lacassagne